Shares of Xtant Medical Holdings Inc. (NYSE American:XTNT) traded today at $4.66, eclipsing its 52-week high. Approximately 72 million shares have changed hands today, as compared to an average 30-day volume of 307,000 shares.
In the past 52 weeks, shares of Xtant Medical Holdings Inc. have traded between a low of $0.55 and a high of $4.66 and is now at $4.40, which is 700% above that low price.
Xtant Medical Holdings Inc. (NYSE American:XTNT) is currently priced 58.5% above its average consensus analyst price target of $1.83.
Xtant Medical Holdings Inc mainly develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The company operates through the single segment of Development, manufacture, and marketing of regenerative medical products and devices. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants, and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders and others.
Receive IBN Spotlights – “Bite Size” Small, Mid and Large-Cap Technical Indicator Alerts
To stay connected with our complimentary IBN Spotlights, please visit https://IBN.fm/connected
About InvestorBrandNetwork (IBN)
InvestorBrandNetwork (IBN) consists of 50+ trusted financial brands introduced to the investment public over the course of 15+ years. Through these brands, IBN provides (1) access to our Investor Press Release Wire Solutions via InvestorWire (IW) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions via IW to ensure maximum impact; (4) full-scale distribution to an enormous social media audience that includes millions of followers; and (5) a full array of corporate communications solutions focused on the IBN Podcast Series. With a proven track record serving 500+ client partners, IBN is the key to a more effective market communication campaign.
For more information, please visit https://www.InvestorBrandNetwork.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer